基于Tecvayli®和Darzalex Faspro®的诱导治疗在符合移植条件的新诊断多发性骨髓瘤患者中展现出令人鼓舞的缓解率和缓解深度

美股速递
Sep 19

基于Tecvayli®和Darzalex Faspro®的诱导治疗在符合移植条件的新诊断多发性骨髓瘤患者中展现出令人鼓舞的缓解率和缓解深度。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10